Trademark: 97315552
Word
COVRIXNAY
Status
Dead
Status Code
604
Status Date
Thursday, April 27, 2023
Serial Number
97315552
Mark Type
4000
Filing Date
Wednesday, March 16, 2022
Published for Opposition
Tuesday, December 27, 2022
Abandoned Date
Thursday, April 27, 2023

Trademark Owner History
GlaxoSmithKline Biologicals SA - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
The wording COVRIXNAY has no meaning in a foreign language.

Trademark Events
Apr 27, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
Apr 27, 2023
Abandonment - After Inter Partes Decision
Apr 27, 2023
Opposition Terminated No. 999999
Apr 27, 2023
Opposition Sustained No. 999999
Jan 26, 2023
Opposition Instituted No. 999999
Jan 26, 2023
Opposition Papers Received At Ttab
Dec 27, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2022
Published For Opposition
Dec 7, 2022
Notification Of Notice Of Publication E-Mailed
Nov 22, 2022
Electronic Record Review Complete
Nov 18, 2022
On Hold - Electronic Record Review Required
Nov 16, 2022
Approved For Pub - Principal Register
Nov 15, 2022
Assigned To Examiner
Aug 2, 2022
Teas Change Of Correspondence Received
Aug 2, 2022
Teas Change Of Domestic Representatives Address
Aug 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2022
New Application Office Supplied Data Entered
Mar 19, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24